ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,365Medicare Part D Prescriptions Filled, Including Refills

Rank: 126 out of 1677

$918K Total Retail Price of All Prescriptions

Rank: 86 out of 1677

464 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 464 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

24% of this provider’s 464 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 10,298 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
HYDROCODONE-ACETAMINOPHEN 577 364 S3 1 4
AMLODIPINE BESYLATE 568 437 2 2
LEVOTHYROXINE SODIUM 520 380 3 5
OMEPRAZOLE 404 289 4 6
PRAVASTATIN SODIUM 319 224 5 10
POTASSIUM CHLORIDE 307 190 6 14
LISINOPRIL 295 156 7 3
GABAPENTIN 290 142 8 11
FUROSEMIDE 280 183 9 8
SIMVASTATIN 270 200 10 1
LOSARTAN POTASSIUM 262 211 11 25
FLUOXETINE HCL 235 142 12 49
ATORVASTATIN CALCIUM 233 169 13 13
CLONIDINE HCL 228 163 14 36
METFORMIN HCL 223 139 15 7
ATENOLOL 223 161 15 21
RANITIDINE HCL 195 108 17 18
ZOLPIDEM TARTRATE 194 113 18 15
GLIMEPIRIDE 188 141 19 33
ALLOPURINOL 176 134 20 31
NAMENDA 166 154 21 39
TRIAMTERENE-HCTZ 159 116 22 61
COLCRYS 144 91 23 141
CITALOPRAM HBR 138 108 24 22
AZITHROMYCIN 134 99 25 38
METOPROLOL TARTRATE 132 106 26 12
NEXIUM 128 79 27 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 125 79 28 17
KLOR-CON M20 125 78 28 65
HYDROCHLOROTHIAZIDE 121 90 30 9
WARFARIN SODIUM 114 72 31 24
MIRTAZAPINE 112 63 32 62
SERTRALINE HCL 109 76 33 26
DIGOXIN 106 85 34 71
FENOFIBRATE 103 50 35 48
CARISOPRODOL 102 40 R 36 68
TRAMADOL HCL 101 64 37 16
LOSARTAN-HYDROCHLOROTHIAZIDE 90 71 38 42
HYDRALAZINE HCL 89 45 39 69
GUANFACINE HCL 87 66 R 40 296
INSULIN SYRINGE 87 58 40 72
DONEPEZIL HCL 86 86 42 30
PREDNISONE 83 62 43 40
LOVASTATIN 83 63 43 35
RISPERIDONE 83 56 43 60
LYRICA 81 46 46 81
CRESTOR 80 51 47 28
SYNTHROID 78 78 48 55
CARVEDILOL 77 25 49 20
LANSOPRAZOLE 76 53 50 147
LANTUS 75 27 51 44
TAMSULOSIN HCL 74 59 52 34
OXYCODONE HCL 74 0 S2 52 91
LEVOFLOXACIN 73 50 54 84
TRAZODONE HCL 73 26 54 37
ZETIA 71 32 56 75
QUETIAPINE FUMARATE 71 43 56 77
PROAIR HFA 71 57 56 50
CYMBALTA 70 28 59 58
METHADONE HCL 70 36 S2 59 168
CELEBREX 68 42 61 102
DILTIAZEM ER 67 66 62 143
CEFPROZIL 67 46 62 306
SINGULAIR 65 46 64 97
ADVAIR DISKUS 64 58 65 54
PIROXICAM 64 56 65 394
AMITRIPTYLINE HCL 62 42 R 67 63
ESCITALOPRAM OXALATE 62 37 67 80
ALPRAZOLAM 62 46 67 153
LIPITOR 61 49 70 101
FAMOTIDINE 60 46 71 41
LEVEMIR FLEXPEN 57 44 72 207
ZOSTAVAX 57 51 72 238
ALENDRONATE SODIUM 56 45 74 43
PAROXETINE HCL 56 35 74 67
COLESTIPOL HCL 56 53 74 411
ROPINIROLE HCL 55 17 77 79
HYDROXYZINE HCL 54 22 R 78 148
METOPROLOL SUCCINATE 54 46 78 23
MELOXICAM 52 38 80 27
AMLODIPINE BESYLATE-BENAZEPRIL 52 52 80 59
NOVOLOG 52 13 80 117
BENAZEPRIL HCL 51 32 83 53
PROMETHAZINE HCL 50 25 R 84 64
DIOVAN 50 38 84 45
TIZANIDINE HCL 50 0 84 108
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 23, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.